The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-6-((1-(4-Chlorophenyl)ethyl)amino)-1-cyclopentyl-5-ethyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one ID: ALA4649440
PubChem CID: 156022066
Max Phase: Preclinical
Molecular Formula: C20H24ClN5O
Molecular Weight: 385.90
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCn1c(N[C@H](C)c2ccc(Cl)cc2)nc2c(cnn2C2CCCC2)c1=O
Standard InChI: InChI=1S/C20H24ClN5O/c1-3-25-19(27)17-12-22-26(16-6-4-5-7-16)18(17)24-20(25)23-13(2)14-8-10-15(21)11-9-14/h8-13,16H,3-7H2,1-2H3,(H,23,24)/t13-/m1/s1
Standard InChI Key: GTKXXNNPQLLFOF-CYBMUJFWSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
31.4041 -3.6856 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.4041 -4.5069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1094 -4.9114 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.1094 -3.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8188 -3.6856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8187 -4.5034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5967 -4.7549 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.0792 -4.0925 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.5968 -3.4302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1094 -2.4474 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.6943 -3.2806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8484 -5.5287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3681 -6.1899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8486 -6.8510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6258 -6.5983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6255 -5.7811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6970 -4.9166 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.6982 -5.7337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9910 -6.1434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2863 -5.7317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5796 -6.1406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5804 -6.9587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2936 -7.3661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9974 -6.9548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8738 -7.3692 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
31.4065 -6.1413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6901 -2.4635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 2 0
1 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
7 12 1 0
2 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
18 26 1 6
11 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.90Molecular Weight (Monoisotopic): 385.1669AlogP: 4.55#Rotatable Bonds: 5Polar Surface Area: 64.74Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.11CX LogP: 3.97CX LogD: 3.97Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.70Np Likeness Score: -1.72
References 1. Wu Y, Tian YJ, Le ML, Zhang SR, Zhang C, Huang MX, Jiang MY, Zhang B, Luo HB.. (2020) Discovery of Novel Selective and Orally Bioavailable Phosphodiesterase-1 Inhibitors for the Efficient Treatment of Idiopathic Pulmonary Fibrosis., 63 (14): [PMID:32603117 ] [10.1021/acs.jmedchem.0c00711 ]